Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.68
+0.06 (1.07%)
Jun 4, 2025, 4:08 PM HKT
24.56%
Market Cap 25.92B
Revenue (ttm) 13.93B
Net Income (ttm) 2.20B
Shares Out 4.56B
EPS (ttm) 0.48
PE Ratio 11.86
Forward PE 10.46
Dividend 0.24 (4.18%)
Ex-Dividend Date Jun 2, 2025
Volume 15,871,496
Average Volume 10,978,165
Open 5.63
Previous Close 5.62
Day's Range 5.60 - 5.79
52-Week Range 3.60 - 6.54
Beta 0.41
RSI 46.72
Earnings Date Aug 28, 2025

About HKG:1066

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China and internationally. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The company’s medical device products include safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions; and ... [Read more]

Sector Healthcare
Founded 1988
Employees 12,719
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1066
Full Company Profile

Financial Performance

In 2024, HKG:1066's revenue was 13.09 billion, a decrease of -1.08% compared to the previous year's 13.23 billion. Earnings were 2.07 billion, an increase of 3.24%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.